New Drug For Schizophrenia
This is a two-part study designed to assess the effects of a new drug (AQW051) for schizophrenia. In the first part, scientists will assess brain function and memory in people with schizophrenia. The second part of the study will involve determining the effects of different doses of the study medication. This national study is currently recruiting patients.
Read moreMore information on "New Drug For Schizophrenia"
From Our Experts
Cross Titer News
It's ten o'clock and I write this from my dining table because I'm awake and wanted to talk about what happened when the medication I took... Read more »
The Year in Review
Ending out the year, I remember the last twelve months on a note of hope. It has been an eventful time in my recovery. Just a year ago this... Read more »
Daring to Dream
Eli Lilly's experimental drug-known as LY2140023-promises to reduce schizophrenic symptoms by acting on glutamate, a key transmitter in the... Read more »
Drug Prices: Part I
Before you read this, I must confess that I have a relative who works for a major pharmaceutical company and is involved in new drug... Read more »
Are Alzheimer’s and Schizophrenia Related?
Medicalnewstoday.com reports that, in a study by neuroscientists at Johns Hopkins, mice "lacking an enzyme that contributes to Alzheimer's... Read more »
From Our Sources
Clinical Trial: Study of a New Drug for Schizophrenia
This is a study to assess the safety and tolerability of multiple doses of a new drug called AQW051 in people with schizophrenia. This national... Read more »
Clinical trial: New drug for schizophrenia
This is a study to examine how well a new drug for schizophrenia--currently known as AQW051--helps enhance various kinds of brain function in people... Read more »
Clinical trial: New drug for schizophrenia
This is a study to compare the effects of a new drug, paliperidone palmitate, with Risperdal Consta in people who suffer from schizophrenia. This... Read more »
Clinical trial: New drug's effect on schizophrenia
This is a study to compare the effects of a new drug for schizophrenia (AL-108) to a placebo in people suffering from schizophrenia. Researchers will... Read more »
New Schizophrenia Drug Effective in New Trial
Danish drugmaker Lundbeck is reporting that its new schizophrenia medication zicronapine was effective in a recent Phase II clinical trial. In the... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
